In vivo, GM-CSF is prominently produced by T cells in inflamed tissue and is also produced by tumor cells (63); further studies are needed to determine how GM-CSF affects the environment in which macrophages associate with laminin-α2 chains. This evidence concerns the gene CSF2 and neoplasm.